Lv11
30 积分 2024-03-04 加入
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
4小时前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
1个月前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
